FDA-cleared profile

MediAI-BA

Crescom Co., Ltd. · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.

Clinical role
Post-processing bone-age measurement/quantification with report generation; optional heatmap is explanatory only
Images and patients
X-ray/Radiography · Left hand and wrist; skeletal maturity/bone age
Key limitation
Keep in mind: Do not rely on results alone for diagnosis. Excluded are growth disorders caused by listed congenital anomalies or other complex skeletal conditions, and images with tumors, fracture sequelae, congenital deformities, or other notable anatomic variations in the required region. Heatmap is supplementary and not for growth-plate localization or independent bone-age assessment; confidence graph is not clinically validated or intended to select a specific bone age.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Left hand and wrist; skeletal maturity/bone age Input: DICOM-compliant 2D PA left-hand radiographs for patients aged 2-18 years, with the entire left hand and wrist visible and without major destruction, deformity, fracture, excessive motion, or other major artifacts.
  • Who uses it?Intended users: Pediatric radiologists
  • What does the software produce?Output: Quantitative bone-age assessment in years and a generated report. An optional heatmap illustrates regions contributing to the model output, and a confidence-score graph illustrates output-distribution sharpness; neither is a clinical diagnosis or independently calibrated clinical likelihood.
  • What is its most important limitation?Key limitation: Do not rely on results alone for diagnosis. Excluded are growth disorders caused by listed congenital anomalies or other complex skeletal conditions, and images with tumors, fracture sequelae, congenital deformities, or other notable anatomic variations in the required region. Heatmap is supplementary and not for growth-plate localization or independent bone-age assessment; confidence graph is not clinically validated or intended to select a specific bone age.

Clinical takeaway. Clinical role: View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.

Evidence takeaway. Evidence from the reviewed source record: An independent FDA performance evaluation used 600 cases aged 2-18 from five US sites and multiple clinical organizations; four evaluators established the reference standard and none of the cases were used for training/development. Deming regression reported slope 1.000 (95% CI 0.989-1.002) and intercept 0.08 (-0.004-0.158). Bland-Altman limits of agreement were -0.66 to 0.71 years; mean difference was 0.026 years with SD 0.3505, and 89% of cases differed by less than 0.5 years. Heatmap testing used 30 cases; the packet reports SSIM criteria results and masking changes in 27 of 30 cases.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
View and quantify bone age from 2D posteroanterior left-hand radiographs to aid pediatric radiologists assessing patients aged 2-18 years.
  • Exact FDA submission
  • Checked 2026-09-08
Workflow role
Post-processing bone-age measurement/quantification with report generation; optional heatmap is explanatory only
  • Exact FDA submission
  • Checked 2026-09-08
Required input
DICOM-compliant 2D PA left-hand radiographs for patients aged 2-18 years, with the entire left hand and wrist visible and without major destruction, deformity, fracture, excessive motion, or other major artifacts.
  • Exact FDA submission
  • Checked 2026-09-08
Output and clinician action
Quantitative bone-age assessment in years and a generated report. An optional heatmap illustrates regions contributing to the model output, and a confidence-score graph illustrates output-distribution sharpness; neither is a clinical diagnosis or independently calibrated clinical likelihood.
  • Exact FDA submission
  • Checked 2026-09-08
Care setting
Healthcare facility/hospital
  • Exact FDA submission
  • Checked 2026-09-08
Intended users
Pediatric radiologists
  • Exact FDA submission
  • Checked 2026-09-08
Limitations
Do not rely on results alone for diagnosis. Excluded are growth disorders caused by listed congenital anomalies or other complex skeletal conditions, and images with tumors, fracture sequelae, congenital deformities, or other notable anatomic variations in the required region. Heatmap is supplementary and not for growth-plate localization or independent bone-age assessment; confidence graph is not clinically validated or intended to select a specific bone age.
  • Exact FDA submission
  • Checked 2026-09-08
Evidence summary
An independent FDA performance evaluation used 600 cases aged 2-18 from five US sites and multiple clinical organizations; four evaluators established the reference standard and none of the cases were used for training/development. Deming regression reported slope 1.000 (95% CI 0.989-1.002) and intercept 0.08 (-0.004-0.158). Bland-Altman limits of agreement were -0.66 to 0.71 years; mean difference was 0.026 years with SD 0.3505, and 89% of cases differed by less than 0.5 years. Heatmap testing used 30 cases; the packet reports SSIM criteria results and masking changes in 27 of 30 cases.
  • Exact FDA submission
  • Checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
An independent FDA performance evaluation used 600 cases aged 2-18 from five US sites and multiple clinical organizations; four evaluators established the reference standard and none of the cases were used for training/development. Deming regression reported slope 1.000 (95% CI 0.989-1.002) and intercept 0.08 (-0.004-0.158). Bland-Altman limits of agreement were -0.66 to 0.71 years; mean difference was 0.026 years with SD 0.3505, and 89% of cases differed by less than 0.5 years. Heatmap testing used 30 cases; the packet reports SSIM criteria results and masking changes in 27 of 30 cases.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Reported sensitivity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

MediAI-BA regulatory performance study summary

  • DesignStand-Alone Performance
  • PopulationPediatric
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K250914
  • Samplen=600
  • Sites5
  • IndependenceIndependence not established

K250914

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K250914. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-08
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM-compliant 2D PA left-hand radiographs for patients aged 2-18 years, with the entire left hand and wrist visible and without major destruction, deformity, fracture, excessive motion, or other major artifacts.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-08 · FDA K250914: MediAI-BA

  2. Routing

    Source context, not route validation: DICOM-compliant image input in a healthcare facility or hospital, with report creation. The FDA packet does not establish a specific PACS, RIS, EHR, or deployment interface.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-08 · FDA K250914: MediAI-BA

  3. AI processing

    Unresolved route: Not established for the exact route.

    Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-08 ·

  4. Returned objects

    Source context, not route validation: Quantitative bone-age assessment in years and a generated report. An optional heatmap illustrates regions contributing to the model output, and a confidence-score graph illustrates output-distribution sharpness; neither is a clinical diagnosis or independently calibrated clinical likelihood.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-08 · FDA K250914: MediAI-BA

  5. Viewer/worklist/report

    Unresolved route: Quantitative bone-age assessment in years and a generated report. An optional heatmap illustrates regions contributing to the model output, and a confidence-score graph illustrates output-distribution sharpness; neither is a clinical diagnosis or independently calibrated clinical likelihood.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-08 · FDA K250914: MediAI-BA

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Integration
DICOM-compliant image input in a healthcare facility or hospital, with report creation. The FDA packet does not establish a specific PACS, RIS, EHR, or deployment interface.
  • Exact FDA submission
  • Checked 2026-09-08

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for MediAI-BA; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-08
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K250914
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Anatomy
Left hand and wrist; skeletal maturity/bone age
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-08
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-12-18
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
23Fields reviewed
9Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-08 - Exact FDA submission

    No public price or quote for the exact K250914 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-08 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Deployment: Not verified - checked 2026-09-08 - Exact FDA submission

    The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-08 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-08 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-08 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K250914: MediAI-BA

    U.S. Food and Drug Administration - Published 2025-12-18 - Accessed 2026-09-08

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. MediAI-BA model card (K250914)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, limitations, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K250914

    U.S. Food and Drug Administration - Accessed 2026-09-08

    Scope: postmarketSafety

Research history

  1. K250914 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252086

DTX Studio Assist

Nobel Biocare C/O Medicim NV

Authorized purpose: Analyzes two-dimensional bitewing and periapical radiographs of permanent teeth in patients aged 15 and older to identify and localize caries, calculus, periapical radiolucency, root canal filling deficiency, discrepancy at an existing restoration margin, and bone loss; also supports alveolar bone-level measurement and restoration/dental-anatomy segmentation as an adjunct to dentist review.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-11-17
FDA-cleared K251747

VEA Align; spineEOS

EOS imaging

Authorized purpose: VEA Align is cloud-based software for orthopedic applications in adult and pediatric populations using two-dimensional X-ray images from EOS imaging systems to display interactive landmarks and assess patient-specific global alignment, with angle and length measurements for spinal deformities, degenerative diseases, and lower-limb alignment disorders or deformities. It is suitable for patients aged 7 years and older. spineEOS assists healthcare professionals with preoperative planning of spine surgery using EOS images, associated three-dimensional datasets, measurements, and patient-specific surgical-planning tools.

Modality
X-ray/Radiography
Anatomy
Spine and lower-limb alignment; frontal and lateral EOS images and associated 3D datasets
Decision
2025-08-15
FDA-cleared K250367

CoLumboX

Smart Soft Healthcare AD

Authorized purpose: Post-processing segmentation, measurement, threshold labeling, and export of quantitative lumbar-spine measurements to support clinical review; not diagnosis.

Modality
X-ray/Radiography
Anatomy
Lumbar spine, including vertebrae and sacrum
Decision
2025-05-28
FDA-cleared K242437

Smile Dx®

Cube Click, Inc.

Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-05-14

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history